{"SPADE_N_14446": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14446", "Peptide Name": "PSTO2 18K (Phylloseptin-TO2 analog, synthetic AMPs, XXA, UCLL1c)", "Source": "amino acid substitution, amphibian peptide analog, animal-derived, natural derivativeamino acid substitution, amphibian peptide analog, animal-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "FLSLIPKAISAVSALAKKL", "Sequence Length": 19, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Antifungal", "Antifungal", "Anti-MRSA", "anti-sepsis", "Hemolytic", "Antibiofilm"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 1970.44, "PI": 10.3, "Hydrophobicity": 1.19, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Yin W, Yao J, Leng X, Ma C, Chen X, Jiang Y, Wang T, Chen T, Shaw C, Zhou M, et al. 2024", "Reference": "Pharmaceutics. 2024; 16(8):1098. https://doi.org/10.3390/pharmaceutics16081098.MDPI", "Title": "Enhancement of Antimicrobial Function by L/D-Lysine Substitution on a Novel Broad-Spectrum Antimicrobial Peptide, Phylloseptin-TO2: A Structure-Related Activity Research Study"}], "Frequent Amino Acids": "ALK", "Absent Amino Acids": "CDEGHMNOQRTUWY", "Basic Residues": 3, "Acidic Residues": 0, "Hydrophobic Residues": 13, "Polar Residues": 11, "Positive Residues": 3, "Negative Residues": 0, "Net Charge": 3, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (94.74%) toPSTO2 7KL=A: 21%, S=K: 16%; I: 11%.Activity: active against Gram+ S. aureus ATCC 6538 or MRSA NCTC 12493 (MIC 2-4 uM), Gram- E. coli ATCC 8739 (MIC 4 uM), A. baumannii BAA 747 (MIC 32 uM),  K. pneumonia ATCC 43816 (MIC 16 uM), P. aeruginosa ATCC 9027 (MIC 32 uM), and fungi C. albicans (MIC 32 uM). Rapid killing at 2xMIC. It binds to LPS.  inhibit biofilms:bacteria (S. aureus and E. coli); eradicate preformed biofilms:S. aureus. eradicate preformed biofilms:E. coli.Structure: random coils in 10 mM NH4Ac and helical in 50% TFE.In vitro toxicity: horse RBC: HC50 64 uM.", "Similar Sequences": [{"SPADE_ID": "SPADE_UN_26439", "Similarity": 1.0, "Sequence": "FLSLIPKAISAVSALAKKL"}, {"SPADE_ID": "SPADE_UN_17620", "Similarity": 1.0, "Sequence": "LAKKLKEYLEKLV"}, {"SPADE_ID": "SPADE_UN_17622", "Similarity": 1.0, "Sequence": "LAKKLAKYLKKAL"}]}}}